AccuStem Sciences Limited
AccuStem Sciences Limited
Share · US00442Y1010 (OTC)
Overview
No Price
n/a
Company Profile for AccuStem Sciences Limited Share
Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.
AI Analysis of AccuStem Sciences Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of AccuStem Sciences Limited
No AI threads available for this company yet.

Company Data

Name AccuStem Sciences Limited
Company AccuStem Sciences Limited
Website https://www.accustem.com
Primary Exchange OTC UTC
ISIN US00442Y1010
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
Country United Kingdom
Currency USD
Employees -
Address 107 Cheapside, EC2V 6DN London
IPO Date 2021-07-21

Ticker Symbols

Name Symbol
Over The Counter ACMSY
More Shares
Investors who hold AccuStem Sciences Limited also have the following shares in their portfolio:
Ekam Leasing and Finance Co. Ltd.
Ekam Leasing and Finance Co. Ltd. Share
SUMMIT WIRELESS TECHNOLOGIESLOGIES INC
SUMMIT WIRELESS TECHNOLOGIESLOGIES INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026